Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Jason J Pitt; Markus Riester; Yonglan Zheng; Toshio F Yoshimatsu; Ayodele Sanni; Olayiwola Oluwasola; Artur Veloso; Emma Labrot; Shengfeng Wang; Abayomi Odetunde; Adeyinka Ademola; Babajide Okedere; Scott Mahan; Rebecca Leary; Maura Macomber; Mustapha Ajani; Ryan S Johnson; Dominic Fitzgerald; A Jason Grundstad; Jigyasa H Tuteja; Galina Khramtsova; Jing Zhang; Elisabeth Sveen; Bryce Hwang; Wendy Clayton; Chibuzor Nkwodimmah; Bisola Famooto; Esther Obasi; Victor Aderoju; Mobolaji Oludara; Folusho Omodele; Odunayo Akinyele; Adewunmi Adeoye; Temidayo Ogundiran; Chinedum Babalola; Kenzie MacIsaac; Abiodun Popoola; Michael P Morrissey; Lin S Chen; Jiebiao Wang; Christopher O Olopade; Adeyinka G Falusi; Wendy Winckler; Kerstin Haase; Peter Van Loo; John Obafunwa; Dimitris Papoutsakis; Oladosu Ojengbede; Barbara Weber; Nasiru Ibrahim; Kevin P White; Dezheng Huo; Olufunmilayo I Olopade; Jordi Barretina

doi:10.1038/s41467-018-07886-4

Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Nat Commun. 2019 Jan 14;10(1):288. doi: 10.1038/s41467-018-07886-4.

Authors

Jason J Pitt^{1

2}, Markus Riester³, Yonglan Zheng⁴, Toshio F Yoshimatsu⁴, Ayodele Sanni⁵, Olayiwola Oluwasola⁶, Artur Veloso³, Emma Labrot³, Shengfeng Wang^{4

7}, Abayomi Odetunde⁸, Adeyinka Ademola⁹, Babajide Okedere⁸, Scott Mahan³, Rebecca Leary³, Maura Macomber³, Mustapha Ajani⁶, Ryan S Johnson³, Dominic Fitzgerald¹, A Jason Grundstad¹, Jigyasa H Tuteja¹, Galina Khramtsova⁴, Jing Zhang⁴, Elisabeth Sveen⁴, Bryce Hwang³, Wendy Clayton⁴, Chibuzor Nkwodimmah⁹, Bisola Famooto⁹, Esther Obasi⁵, Victor Aderoju¹⁰, Mobolaji Oludara¹⁰, Folusho Omodele¹⁰, Odunayo Akinyele⁴, Adewunmi Adeoye⁶, Temidayo Ogundiran⁹, Chinedum Babalola^{8

11}, Kenzie MacIsaac³, Abiodun Popoola¹², Michael P Morrissey³, Lin S Chen¹³, Jiebiao Wang¹³, Christopher O Olopade⁴, Adeyinka G Falusi⁸, Wendy Winckler³, Kerstin Haase¹⁴, Peter Van Loo^{14

15}, John Obafunwa⁵, Dimitris Papoutsakis³, Oladosu Ojengbede¹⁶, Barbara Weber³, Nasiru Ibrahim¹⁰, Kevin P White^{17

18}, Dezheng Huo^{19

20}, Olufunmilayo I Olopade^{21

22}, Jordi Barretina^{23

24}

Affiliations

¹ Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
² Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore.
³ Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
⁴ Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
⁵ Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
⁶ Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
⁷ Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
⁸ Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
⁹ Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
¹⁰ Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
¹¹ Department of Pharmaceutical Chemistry, University of Ibadan, Ibadan, Oyo, Nigeria.
¹² Oncology Unit, Department of Radiology, Lagos State University, Ikeja, Lagos, Nigeria.
¹³ Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA.
¹⁴ The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
¹⁵ Department of Human Genetics, University of Leuven, Oude Markt 13, Leuven 3000, Belgium.
¹⁶ Centre for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
¹⁷ Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. kpwhite@uchicago.edu.
¹⁸ Tempus Labs, Inc., Chicago, IL, USA. kpwhite@uchicago.edu.
¹⁹ Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. dhuo@health.bsd.uchicago.edu.
²⁰ Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA. dhuo@health.bsd.uchicago.edu.
²¹ Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. folopade@medicine.bsd.uchicago.edu.
²² Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. folopade@medicine.bsd.uchicago.edu.
²³ Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA. jordi.barretina@gmail.com.
²⁴ Girona Biomedical Research Institute (IDIBGI), 17007, Girona 17007, Spain. jordi.barretina@gmail.com.

Abstract

The original version of this Article contained an error in the author affiliations. The affiliation of Kevin P. White with Tempus Labs, Inc. Chicago, IL, USA was inadvertently omitted. This has now been corrected in both the PDF and HTML versions of the Article.

Publication types

Published Erratum

Grants and funding

U01-CA161032/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)/International